NEWS │ RESEARCH
Findings regarding new origin of breast cancer presented at ASCO 2022
In an interview with journalist Julie Kalveland from Dagens Medisin (04.06.2022) Professor Per Eystein Lønning shares the most important findings from a Norwegian-American collaboration study on BRCA1-methylation in breast and ovarian cancer. These findings were presented orally by Lønning at ASCO (03.06.2022).
Photo:
Screenshot from Dagens Medisin_04.06.2022
Main content
Updated: 20.06.2022 (First published: 07.06.2022)
See the full interview and read more on the webpages of Dagens Medisin (Only in Norwegian).